SET-M33L
N/A
Report date: 2026/01/29 16:01:16
Base Information
Drug NameSET-M33L
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[7]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSetLance Srl
China Registration ClassN/A
Develop Information
Active CompaniesErasmus University Medical Center
Inactive CompaniesEudax SrlSetLance Srl
Active Indications
Inactive Indications +[6]
Other Information
ATC CodeN/A
Related LinksN/A